159 related articles for article (PubMed ID: 9111073)
1. A two-site model for ApoB degradation in HepG2 cells.
Wu X; Sakata N; Lele KM; Zhou M; Jiang H; Ginsberg HN
J Biol Chem; 1997 Apr; 272(17):11575-80. PubMed ID: 9111073
[TBL] [Abstract][Full Text] [Related]
2. Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells.
Furukawa S; Sakata N; Ginsberg HN; Dixon JL
J Biol Chem; 1992 Nov; 267(31):22630-8. PubMed ID: 1429611
[TBL] [Abstract][Full Text] [Related]
3. Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of ApoB-containing lipoprotein particles in HepG2 cells.
Macri J; Adeli K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2982-94. PubMed ID: 9409285
[TBL] [Abstract][Full Text] [Related]
4. Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells.
Sakata N; Wu X; Dixon JL; Ginsberg HN
J Biol Chem; 1993 Nov; 268(31):22967-70. PubMed ID: 8226809
[TBL] [Abstract][Full Text] [Related]
5. In HepG2 cells, translocation, not degradation, determines the fate of the de novo synthesized apolipoprotein B.
Bonnardel JA; Davis RA
J Biol Chem; 1995 Dec; 270(48):28892-6. PubMed ID: 7499417
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters.
Borradaile NM; de Dreu LE; Barrett PH; Huff MW
J Lipid Res; 2002 Sep; 43(9):1544-54. PubMed ID: 12235187
[TBL] [Abstract][Full Text] [Related]
7. The production of 85 kDa N-terminal fragment of apolipoprotein B in mutant HepG2 cells generated by targeted modification of apoB gene occurs by ALLN-inhibitable protease cleavage during translocation.
Srivastava N; Cefalu AB; Noto D; Schonfeld G; Averna M; Srivastava RA
Biochem Biophys Res Commun; 2010 Aug; 398(4):665-70. PubMed ID: 20609357
[TBL] [Abstract][Full Text] [Related]
8. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway.
Wang Q; Theriault A; Gapor A; Adeli K
Biochem Biophys Res Commun; 1998 May; 246(3):640-3. PubMed ID: 9618265
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B.
Yeung SJ; Chen SH; Chan L
Biochemistry; 1996 Oct; 35(43):13843-8. PubMed ID: 8901527
[TBL] [Abstract][Full Text] [Related]
10. Regulated intracellular degradation of apolipoprotein B in semipermeable HepG2 cells.
Adeli K
J Biol Chem; 1994 Mar; 269(12):9166-75. PubMed ID: 8132654
[TBL] [Abstract][Full Text] [Related]
11. Intracellular mechanisms regulating apoB-containing lipoprotein assembly and secretion in primary hamster hepatocytes.
Taghibiglou C; Rudy D; Van Iderstine SC; Aiton A; Cavallo D; Cheung R; Adeli K
J Lipid Res; 2000 Apr; 41(4):499-513. PubMed ID: 10744770
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein B-100 destined for lipoprotein assembly and intracellular degradation undergoes efficient translocation across the endoplasmic reticulum membrane.
Ingram MF; Shelness GS
J Lipid Res; 1996 Oct; 37(10):2202-14. PubMed ID: 8906597
[TBL] [Abstract][Full Text] [Related]
13. Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor.
Taghibiglou C; Van Iderstine SC; Kulinski A; Rudy D; Adeli K
Biochem Pharmacol; 2002 Feb; 63(3):349-60. PubMed ID: 11853686
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of apolipoprotein E degradation in a post-Golgi compartment by a cysteine protease inhibitor.
Ye SQ; Reardon CA; Getz GS
J Biol Chem; 1993 Apr; 268(12):8497-502. PubMed ID: 8473293
[TBL] [Abstract][Full Text] [Related]
15. Heterologous expression of apolipoprotein B carboxyl-terminal truncates: a model for the study of lipoprotein biogenesis.
Patel SB; Grundy SM
J Lipid Res; 1995 Oct; 36(10):2090-103. PubMed ID: 8576636
[TBL] [Abstract][Full Text] [Related]
16. Intracellular degradation of apolipoprotein B generates an N-terminal 70 kDa fragment in the endoplasmic reticulum.
Sallach SM; Adeli K
Biochim Biophys Acta; 1995 Feb; 1265(1):29-32. PubMed ID: 7857981
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane lipid transfer is crucial for providing neutral lipids during very low density lipoprotein assembly in endoplasmic reticulum.
Higashi Y; Itabe H; Fukase H; Mori M; Fujimoto Y; Takano T
J Biol Chem; 2003 Jun; 278(24):21450-8. PubMed ID: 12670935
[TBL] [Abstract][Full Text] [Related]
18. The conversion of apoB100 low density lipoprotein/high density lipoprotein particles to apoB100 very low density lipoproteins in response to oleic acid occurs in the endoplasmic reticulum and not in the Golgi in McA RH7777 cells.
Yamaguchi J; Gamble MV; Conlon D; Liang JS; Ginsberg HN
J Biol Chem; 2003 Oct; 278(43):42643-51. PubMed ID: 12917397
[TBL] [Abstract][Full Text] [Related]
19. Intracellular degradation of newly synthesized apolipoprotein B.
Yao Z; Tran K; McLeod RS
J Lipid Res; 1997 Oct; 38(10):1937-53. PubMed ID: 9374117
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the endoplasmic reticulum 60 protein ER-60 downregulates apoB100 secretion by inducing its intracellular degradation via a nonproteasomal pathway: evidence for an ER-60-mediated and pCMB-sensitive intracellular degradative pathway.
Qiu W; Kohen-Avramoglu R; Rashid-Kolvear F; Au CS; Chong TM; Lewis GF; Trinh DK; Austin RC; Urade R; Adeli K
Biochemistry; 2004 Apr; 43(16):4819-31. PubMed ID: 15096051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
